Are delayed-start design trials to show neuroprotection in Parkinson's disease fundamentally flawed?

Carl Clarke

    Research output: Contribution to journal › Article

    40 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Are delayed-start design trials to show neuroprotection in Parkinson's disease fundamentally flawed?'. Together they form a unique fingerprint.

    Medicine & Life Sciences